Ipramol Steri-Neb

Ipratropium bromide and salbutamol, the active ingredients in Ipramol Steri-Neb, are a combination bronchodilator presented as an inhalation solution for inhalation use. It treats bronchospasm associated with chronic obstructive pulmonary disease and asthma in adult patients.

GNH USA supplies Ipramol Steri-Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipramol Steri-Neb, a combination bronchodilator, is used to manage airway obstruction in obstructive lung diseases.

- COPD: reduces bronchospasm and improves airflow during acute exacerbations. - Asthma: provides rapid relief of bronchoconstriction in acute asthma attacks. - Acute bronchospasm: offers prompt bronchodilation to alleviate sudden airway narrowing.

Adverse reactions to Ipramol Steri-Neb may vary in frequency and severity.

Common Side Effects: - Dry mouth: sensation of dryness in the oral cavity. - Cough: transient irritation leading to coughing. - Throat irritation: discomfort or soreness in the throat. - Tremor: mild shaking of hands or limbs. - Headache: mild to moderate head pain. - Palpitations: awareness of heart beating faster or irregularly.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of airway constriction after inhalation. - Tachyarrhythmia: rapid or irregular heart rhythm. - Angioedema: swelling of face, lips, or airway. - Severe hypersensitivity: rash, itching, or anaphylactic reaction. - Cardiac ischemia: chest pain due to reduced heart blood flow.

Before prescribing Ipramol Steri-Neb, clinicians should consider several safety precautions. - Cardiac assessment: evaluate for existing heart disease or arrhythmias. - Glaucoma caution: avoid in patients with narrow‑angle glaucoma. - Monitor paradoxical bronchospasm: watch for worsening breathing after first dose. - Hypersensitivity screening: ensure no known allergy to ipratropium or salbutamol. - Use with caution in severe COPD: adjust therapy based on response. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Ipramol Steri-Neb can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may diminish bronchodilator effect and provoke bronchospasm. - MAO inhibitors: increase risk of cardiovascular side effects when combined with salbutamol. - Anticholinergic overload: concurrent use of other anticholinergics can enhance dry‑mouth and urinary retention.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate hypokalemia induced by salbutamol. - Theophylline: combined use can increase risk of tachycardia and tremor. - Tricyclic antidepressants: may potentiate cardiovascular effects. - Digoxin: salbutamol may raise serum digoxin levels, requiring monitoring.